Medical Cannabis News
Investment
Cultivation
Supply Chain
Research & Innovation
Products
Pharma
Policy & Regulation
Special Reports
eBooks
Partners
Publications
Search
Thursday, April 25, 2024
Contact Us
MCN Home
MCN Editorial Board
Back to Health Europa
Investment
Cultivation
Supply
Research
Products
Pharma
Policy
Special Reports
eBooks
Partners
Publications
Home
Tags
Swiss PharmaCan AG
Swiss PharmaCan AG Related News
The absorption of CBD: does CBD oil have no future?
23rd August 2019
Every time we use CBD oil we throw away 90-95% of the CBD because it is not absorbed by the body. How long will...
Latest Partner News
ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma
Partner News
23rd April 2024
Chiesi Group celebrates €3bn sales success in 2023
Partner News
22nd April 2024
B Medical Systems’ TCW40SDD receives ACT label from My Green Lab
Partner News
16th April 2024
Health Special Reports
Digital trends that are revolutionising the medical cold chain
Special Reports
8th April 2024
Correctly transporting pharmaceutical products and biospecimens to ensure patient safety and...
Special Reports
13th October 2023
New study links 2-in-1 wipes with reduced in-hospital mortality
Special Reports
24th July 2023
Health eBooks
GAMA Healthcare: preventing infections in healthcare settings
eBooks
3rd January 2024
Meeting of minds: Advancing research into neurological disease diagnosis and treatment
eBooks
15th September 2022
Health Partners
Discover B Medical Systems’ medical refrigerators, freezers, and transport boxes
Partner Profiles
12th April 2024
BioNxt makes bold move into proprietary MS drug formulation market
Partner Profiles
16th February 2024
Vektor Pharma: leaders in thin film drug formulations
Partner Profiles
12th January 2024
Pin It on Pinterest
Edit with Live CSS
